[Source](https://github.com/mm80843/T3.5/blob/main/docs/index.md) -- [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) 

# RiskMitigation: __Use of specific medicines__ (PBN__Mitigation_1555)

## Property: has_MitigationRisk

* [nan](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_295.md)

## Property: has_MitigationPrinciple

Repurposing existing medicines such as anti-bacterial, antimalarial, and antiviral drugs, as well as protease inhibitors and corticosteroids, for the treatment of COVID-19. These medicines are used to reduce the severity of symptoms and prevent complications in infected individuals.

## Property: has_MitigationSource

* [paital_nurture_2020](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_44.md)

## Property: has_MitigationTechnology

* [anti-bacterial](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3917.md)
* [antimalarial](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3918.md)
* [antiviral](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3919.md)
* [protease inhibitors](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3920.md)
* [corticosteroids](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3921.md)

